These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2664125)

  • 21. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.
    Gratieri T; Kalia YN
    Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of permeation enhancer pretreatment on the iontophoresis of luteinizing hormone releasing hormone (LHRH) through human epidermal membrane (HEM).
    Smyth HD; Becket G; Mehta S
    J Pharm Sci; 2002 May; 91(5):1296-307. PubMed ID: 11977105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iontophoretic delivery of nonpeptide drugs: formulation optimization for maximum skin permeability.
    Sanderson JE; de Riel S; Dixon R
    J Pharm Sci; 1989 May; 78(5):361-4. PubMed ID: 2664124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and therapeutic applications of iontophoresis.
    Sieg A; Wascotte V
    J Drug Target; 2009 Nov; 17(9):690-700. PubMed ID: 19845485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced Transdermal Drug Delivery by Sonophoresis and Simultaneous Application of Sonophoresis and Iontophoresis.
    Park J; Lee H; Lim GS; Kim N; Kim D; Kim YC
    AAPS PharmSciTech; 2019 Jan; 20(3):96. PubMed ID: 30694397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
    Nair A; Vyas H; Shah J; Kumar A
    Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal iontophoretic delivery of bovine insulin and monomeric human insulin analogue.
    Kanikkannan N; Singh J; Ramarao P
    J Control Release; 1999 May; 59(1):99-105. PubMed ID: 10210726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal delivery of regular insulin to chronic diabetic rats: effect of skin preparation and electrical enhancement.
    Zakzewski CA; Wasilewski J; Cawley P; Ford W
    J Control Release; 1998 Jan; 50(1-3):267-72. PubMed ID: 9685893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal iontophoresis of insulin. V. Effect of terpenes.
    Pillai O; Panchagnula R
    J Control Release; 2003 Mar; 88(2):287-96. PubMed ID: 12628335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal macromolecular delivery: real-time visualization of iontophoretic and chemically enhanced transport using two-photon excitation microscopy.
    Grewal BS; Naik A; Irwin WJ; Gooris G; de Grauw CJ; Gerritsen HG; Bouwstra JA
    Pharm Res; 2000 Jul; 17(7):788-95. PubMed ID: 10990196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled transdermal iontophoresis by ion-exchange fiber.
    Jaskari T; Vuorio M; Kontturi K; Urtti A; Manzanares JA; Hirvonen J
    J Control Release; 2000 Jul; 67(2-3):179-90. PubMed ID: 10825552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transport mechanisms in iontophoresis. I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis.
    Pikal MJ
    Pharm Res; 1990 Feb; 7(2):118-26. PubMed ID: 2308891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic effects of iontophoresis and jet injector pretreatment on the in-vitro skin permeation of diclofenac and angiotensin II.
    Sugibayashi K; Kagino M; Numajiri S; Inoue N; Kobayashi D; Kimura M; Yamaguchi M; Morimoto Y
    J Pharm Pharmacol; 2000 Oct; 52(10):1179-86. PubMed ID: 11092561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of charge and molecular weight on transdermal peptide delivery by iontophoresis.
    Abla N; Naik A; Guy RH; Kalia YN
    Pharm Res; 2005 Dec; 22(12):2069-78. PubMed ID: 16170597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation into the potential of iontophoresis facilitated delivery of ketorolac.
    Tiwari SB; Udupa N
    Int J Pharm; 2003 Jul; 260(1):93-103. PubMed ID: 12818814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A combination of iontophoresis and the chelating agent 1,10 phenanthroline act synergistically as penetration enhancers.
    Brand RM; Hannah TL; Hamel FG
    AAPS PharmSci; 2000; 2(4):E35. PubMed ID: 11741251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-permeation relationships for the non-invasive transdermal delivery of cationic peptides by iontophoresis.
    Schuetz YB; Carrupt PA; Naik A; Guy RH; Kalia YN
    Eur J Pharm Sci; 2006 Sep; 29(1):53-9. PubMed ID: 16837178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of liposomal drug formulations for transdermal iontophoretic drug delivery.
    Malinovskaja-Gomez K; Espuelas S; Garrido MJ; Hirvonen J; Laaksonen T
    Eur J Pharm Sci; 2017 Aug; 106():294-301. PubMed ID: 28625748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro.
    Kumar MG; Lin S
    Pharm Dev Technol; 2009; 14(1):106-15. PubMed ID: 18825546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.